![]() |
市场调查报告书
商品编码
1643892
全球一次性医疗感测器市场 - 2025-2033Global Disposable Medical Sensors Market - 2025-2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024年,全球一次性医疗感测器市场规模达到117亿美元,预计2033年将达到370亿美元,2025-2033年预测期间复合年增长率为13.3%。
一次性医疗感测器是紧凑、轻巧且经济高效的设备,用于医疗保健环境中,用于检测和测量身体的生理变化。它们测量温度、心率、呼吸频率、血糖水平和氧饱和度等参数。常见应用包括患者监测、糖尿病管理和检测感染。它们的一次性特性降低了交叉污染风险,提高了病患安全,并简化了设备处理和维护。
驱动程式和限制
不断进步的技术
技术进步对全球一次性医疗感测器市场产生了重大影响,导致了更小、更有效率的感测器的开发,这些感测器可以整合到穿戴式装置、贴片和可植入系统中。这些感测器能够持续监测患者的生命征象、血糖水平和心臟活动,从而减少就诊次数并促进主动的医疗保健管理。材料科学的进步使得感测器具有更高的生物相容性、耐用性和灵敏度,确保最大限度地减少不适并改善临床结果。蓝牙和 NFC 等无线通讯技术增强了一次性感测器的可用性,实现了向智慧型手机、云端系统和医疗设备的无缝资料传输,这对于远端患者监护和远距医疗至关重要。
例如,2024 年 1 月,美敦力 (Medtronic) 的 MiniMed 780G 系统与 Simplera Sync(一款一次性一体式连续血糖监测仪)获得了 CE 标誌批准。该设备无需指尖采血或过度粘贴,可提供改进的用户体验,尺寸只有以前的美敦力感测器的一半。
有限的监管批准和标准
全球一次性医疗感测器市场受到有限的监管批准和标准的阻碍。医疗器材的审批流程因地区而异,为製造商创造了一个复杂的环境。缺乏统一的全球标准可能会导致产品开发的延迟、成本的增加以及新感测器的上市时间。监管政策的变化或不一致也会扰乱市场,使製造商难以维持一致的产品供应。因此,一次性医疗感测器的引入减缓了整个行业的成长。
The global disposable medical sensors market reached US$ 11.7 billion in 2024 and is expected to reach US$ 37.0 billion by 2033, growing at a CAGR of 13.3% during the forecast period 2025-2033.
Disposable medical sensors are compact, lightweight, and cost-effective devices used in healthcare settings to detect and measure physiological changes in the body. They measure parameters like temperature, heart rate, respiratory rate, glucose levels, and oxygen saturation. Common applications include patient monitoring, diabetes management, and detecting infections. Their disposable nature reduces cross-contamination risk, enhances patient safety, and simplifies device handling and maintenance.
Market Dynamics: Drivers & Restraints
Increasing Technological Advancements
Technological advancements have significantly impacted the global disposable medical sensors market, leading to the development of smaller, more efficient sensors that can be integrated into wearable devices, patches, and implantable systems. These sensors enable continuous patient monitoring for vital signs, glucose levels, and cardiac activity, reducing hospital visits and promoting proactive healthcare management. Materials science advancements have led to sensors with higher biocompatibility, durability, and sensitivity, ensuring minimal discomfort and improved clinical outcomes. Wireless communication technologies like Bluetooth and NFC have enhanced the usability of disposable sensors, enabling seamless data transmission to smartphones, cloud systems, and medical devices, crucial for remote patient monitoring and telemedicine.
For instance, in January 2024, Medtronic has received CE Mark approval for its MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor. This device requires no fingersticks or overtape, offers an improved user experience, and is half the size of previous Medtronic sensors.
Limited Regulatory Approvals and Standards
The global disposable medical sensors market is hindered by limited regulatory approvals and standards. The approval process for medical devices varies across regions, creating a complex landscape for manufacturers to navigate. This lack of uniform global standards can lead to delays in product development, increased costs, and time-to-market for new sensors. Changes or inconsistencies in regulatory policies can also disrupt the market, making it difficult for manufacturers to maintain consistent product offerings. As a result, the introduction of disposable medical sensors slows overall industry growth.
The global disposable medical sensors market is segmented based on product type, sensor type, application, end user and region.
Biosensors segment is expected to dominate the Disposable Medical Sensors market share
The biosensors segment holds a major portion of the disposable medical sensors market share and is expected to continue to hold a significant portion of the disposable medical sensors market share during the forecast period.
Biosensors are vital in the global disposable medical sensors market, providing real-time monitoring of biological markers essential for patient care and disease management. These sensors detect biochemical reactions, allowing continuous monitoring of critical parameters like glucose levels, blood oxygen saturation, and lactate levels. Biosensors are cost-effective, easy to use, and disposable after a single use, reducing infection risk and enhancing patient safety. The growing prevalence of chronic diseases like diabetes and cardiovascular disorders drives demand for biosensors in clinical and home healthcare settings. As biosensor technology advances, they are expected to play a more integral role in personalizing healthcare and improving patient outcomes.
For instance, in January 2023, a new biosensor chip developed by NIST, Brown University, and CEA-Leti identifies biomarkers by measuring binding between DNA strands and the device. This modular design lowers costs by making it easier to mass produce and allowing the most expensive components to be reused. This could increase accessibility to high-quality diagnostics, as traditional methods can be laborious, expensive, or limited in their findings.
Application:-
Patient Monitoring segment is the fastest-growing segment in Disposable Medical Sensors market share
The patient monitoring segment is the fastest-growing segment in the disposable medical sensors market share and is expected to hold the market share over the forecast period.
Patient monitoring is among the fastest-growing sections of the market, and disposable sensors are fast becoming standard with regard to patient monitoring. In both the rural and urban areas of developing countries, there has emerged a growing demand for in-home patient monitoring. Such increasing demand has permitted companies to rely heavily on medical device sensors for patient monitoring purposes.Remote patient monitoring helps doctors and hospitals maintain a watch on patients outside the traditional setting of the clinic, where technology can help provide 24/7 data between patients and physicians.
For instance, in January 2023, Blue Spark Technologies is launching a unique multi-sensor remote patient monitoring platform, VitalTraq, which includes a contactless vital sign measurement sensor, Remote Photoplethysmography (rPPG). This allows patients, clinicians, and researchers to collect digital measurements of vital signs like Heart Rate, Heart Rate Variability, Blood Pressure, and Respiratory Rate in a single contactless patient experience.
North America is expected to hold a significant position in the Disposable Medical Sensors market share
North America holds a substantial position in the disposable medical sensors market and is expected to hold most of the market share due to strong healthcare infrastructure, rising healthcare spending, and advanced technology. The region's emphasis on improving patient outcomes and optimizing healthcare delivery encourages the use of disposable medical sensors in hospitals, clinics, and home-care settings. The rising prevalence of chronic diseases like diabetes and cardiovascular conditions demands continuous monitoring, which disposable medical sensors can efficiently address. Key market players and significant sensor innovation investments further accelerate market growth.
For instance, according to Centers for Medicare & Medicaid Services in 2023, health care spending grew 7.5% to US$ 4.9 trillion, reaching US$ 14,570 per person, accounting for 17.6% of the nation's Gross Domestic Product.
Hence, the rising healthcare costs necessitate cost-effective solutions for patient monitoring and outcomes. Disposable medical sensors offer real-time monitoring for various conditions, enabling continuous tracking of vital signs, chronic disease management, and early detection, potentially reducing hospital readmissions and emergency care costs. This trend is expected to accelerate the disposable medical sensors market growth.
Europe is growing at the fastest pace in the Disposable Medical Sensors market
Europe holds the fastest pace in the disposable medical sensors market and is expected to hold most of the market share due to robust healthcare systems, government investments, and favourable reimbursement policies are encouraging the integration of disposable sensors for preventive care and chronic disease management. The adoption of wearable and remote patient monitoring devices is growing due to the convenience and cost-effectiveness of these devices. The strong regulatory framework in Europe ensures then safety and efficacy of medical devices, fostering trust in disposable medical sensors.
For instance, in May 2024, Dexcom has launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK, using Dexcom's established sensor design and user feedback. The platform is designed for people treating type 1 or type 2 diabetes with insulin, using the latest-generation G7 sensor. The CGM is expected to be completed in Q1 2024. The system also adds notes at specific moments, such as meals, insulin administration, and sports activities, replacing traditional fingersticks to provide a clear picture of how daily choices affect glucose levels.
The major global players in the disposable medical sensors market include Medtronic Plc, Honeywell International, Inc, GE Healthcare, Koninklijke Philips N.V, Sensirion AG, Analog Devices, Inc, Gentag Inc, Smiths Medical, ACE Medical Devices, Abbott Laboratories and among others.
The global disposable medical sensors market report delivers a detailed analysis with 70+ key tables, more than 65 visually impactful figures, and 234 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
Key Market Players
Emerging Market Players
LIST NOT EXHAUSTIVE